Lacal JC - Search Results

1

Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins.

Perona R, Montaner S, Saniger L, Sánchez-Pérez I, Bravo R, Lacal JC. Perona R, et al. Among authors: lacal jc. Genes Dev. 1997 Feb 15;11(4):463-75. doi: 10.1101/gad.11.4.463. Genes Dev. 1997. PMID: 9042860 Free article.

2

Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases.

Montaner S, Perona R, Saniger L, Lacal JC. Montaner S, et al. Among authors: lacal jc. J Biol Chem. 1998 May 22;273(21):12779-85. doi: 10.1074/jbc.273.21.12779. J Biol Chem. 1998. PMID: 9582304 Free article.

3

Activation of serum response factor by RhoA is mediated by the nuclear factor-kappaB and C/EBP transcription factors.

Montaner S, Perona R, Saniger L, Lacal JC. Montaner S, et al. Among authors: lacal jc. J Biol Chem. 1999 Mar 26;274(13):8506-15. doi: 10.1074/jbc.274.13.8506. J Biol Chem. 1999. PMID: 10085083 Free article.

4

Cell stress and MEKK1-mediated c-Jun activation modulate NFkappaB activity and cell viability.

Sánchez-Pérez I, Benitah SA, Martínez-Gomariz M, Lacal JC, Perona R. Sánchez-Pérez I, et al. Among authors: lacal jc. Mol Biol Cell. 2002 Aug;13(8):2933-45. doi: 10.1091/mbc.e02-01-0022. Mol Biol Cell. 2002. PMID: 12181357 Free PMC article.

5

Overexpression of PKC zeta in NIH3T3 cells does not induce cell transformation nor tumorigenicity and does not alter NF kappa B activity.

Montaner S, Ramos A, Perona R, Esteve P, Carnero A, Lacal JC. Montaner S, et al. Among authors: lacal jc. Oncogene. 1995 Jun 1;10(11):2213-20. Oncogene. 1995. PMID: 7784066

6

Induction of apoptosis in NIH3T3 cells after serum deprivation by overexpression of rho-p21, a GTPase protein of the ras superfamily.

Jiménez B, Arends M, Esteve P, Perona R, Sánchez R, Ramón y Cajal S, Wyllie A, Lacal JC. Jiménez B, et al. Among authors: lacal jc. Oncogene. 1995 Mar 2;10(5):811-6. Oncogene. 1995. PMID: 7898922

7

Tumorigenic activity of rho genes from Aplysia californica.

Perona R, Esteve P, Jiménez B, Ballestero RP, Ramón y Cajal S, Lacal JC. Perona R, et al. Among authors: lacal jc. Oncogene. 1993 May;8(5):1285-92. Oncogene. 1993. PMID: 8479750

8

Choline kinase inhibitors as a novel approach for antiproliferative drug design.

Hernández-Alcoceba R, Saniger L, Campos J, Núñez MC, Khaless F, Gallo MA, Espinosa A, Lacal JC. Hernández-Alcoceba R, et al. Among authors: lacal jc. Oncogene. 1997 Nov 6;15(19):2289-301. doi: 10.1038/sj.onc.1201414. Oncogene. 1997. PMID: 9393874

9

Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway.

Esteve P, Embade N, Perona R, Jiménez B, del Peso L, León J, Arends M, Miki T, Lacal JC. Esteve P, et al. Among authors: lacal jc. Oncogene. 1998 Oct 8;17(14):1855-69. doi: 10.1038/sj.onc.1202082. Oncogene. 1998. PMID: 9778052

10

Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation.

Aznar S, Valerón PF, del Rincon SV, Pérez LF, Perona R, Lacal JC. Aznar S, et al. Among authors: lacal jc. Mol Biol Cell. 2001 Oct;12(10):3282-94. doi: 10.1091/mbc.12.10.3282. Mol Biol Cell. 2001. PMID: 11598209 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters